Synergistic Combinations of Multiple Chemotherapeutic Agents in High Capacity Poly(2-oxazoline) Micelles
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Many effective drugs for cancer treatment are poorly water-soluble. In combination chemotherapy, needed excipients in additive formulations are often toxic and restrict their applications in clinical intervention. Here, we report on amphiphilic poly(2-oxazoline)s (POx) micelles as a promising high capacity delivery platform for multidrug cancer chemotherapy. A variety of binary and ternary drugs combinations of paclitaxel (PTX), docetaxel (DTX), 17-allylamino-17-demethoxygeldanamycin (17-AAG), etoposide (ETO) and bortezomib (BTZ) were solubilized in defined polymeric micelles achieving unprecedented high total loading capacities of up to 50 wt % drug per final formulation. Multidrug loaded POx micelles showed enhanced stability in comparison to single-drug loaded micelles. Drug ratio dependent synergistic cytotoxicity of micellar ETO/17-AAG was observed in MCF-7 cancer cells and of micellar BTZ/17-AAG in MCF-7, PC3, MDA-MB-231 and HepG2 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A number of other hydrophobic drugs such as etoposide, 3rd generation of taxanes, and vismodegib as well as multiple drug combinations were shown to be solubilized in the POx micelle system with high loading [113, 117, 118].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Han et al. reported the synergistic solubilization of multiple drugs in a single micelle system with high LC resulting in formation of ultra-high loaded polymeric micelle drug formulations.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For many drugs, the aqueous POx micelle solutions can be readily prepared that contain 10 to 50 g/L of extremely poorly soluble drug and are stable for days and weeks.”
From Co-delivery of Paclitaxel and Cisplatin in Poly(2-oxazoline) Polymeric Micelles: Implications for Drug Loading, Release, Pharmacokinetics and Outcome of Ovarian and Breast Cancer Treatments (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, PTX POx micelles have ca. 4 to 100 times higher drug loading and ca. 10 to 20 times higher drug concentration than the current PTX clinical formulations Taxol, Genexol-PM, and Abraxane.”
From Co-delivery of Paclitaxel and Cisplatin in Poly(2-oxazoline) Polymeric Micelles: Implications for Drug Loading, Release, Pharmacokinetics and Outcome of Ovarian and Breast Cancer Treatments (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The solubility of these drugs in POx micelles system is increased by a factor of 1,000 to 100,000 times.”
From Co-delivery of Paclitaxel and Cisplatin in Poly(2-oxazoline) Polymeric Micelles: Implications for Drug Loading, Release, Pharmacokinetics and Outcome of Ovarian and Breast Cancer Treatments (2019) · cites this paper as [13]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sain, N., Krishnan, B., Ormerod, M. G., Rienzo, A. D., Liu, W. M., Kaye, S. B., Workman, P., & Jackman, A. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0445 · Cited by 92
RetractedProspective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
The proteasome: a suitable antineoplastic target
Adams, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1361 · Cited by 1,201
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Research works printed but not linked: 1
- Teicher B. A., 1999, Clin. Cancer Res., 5, 2638
Cited by
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
Self-citationPolymeric micelles in cancer therapy: State of the art
Ghosh, B., & Biswas, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.016 · Cited by 546
Polymeric nanoparticles: the future of nanomedicine
Banik, B. L., Fattahi, P., & Brown, J. L. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1364 · Cited by 485
Poly (2-oxazoline) s as polymer therapeutics
Luxenhofer, R., Han, Y., Schulz, A., Tong, J., He, Z., Kabanov, A. V., & Jordan, R. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200354 · Cited by 470
Self-citationNanocarriers for delivery of platinum anticancer drugs
Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 396
Self-citationPoly(2-oxazoline)s based biomaterials: a comprehensive and critical update
Lorson, T., Lübtow, M. M., Wegener, E., Haider, M. S., Borova, S., Nahm, D., Jordan, R., Sokolski-Papkov, M., Kabanov, A. V., & Luxenhofer, R. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.022 · Cited by 391
Self-citationOn the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s
Ulbricht, J., Jordan, R., & Luxenhofer, R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.029 · Cited by 348
Self-citationAccelerating the Translation of Nanomaterials in Biomedicine
Mitragotri, S., Anderson, D. G., Chen, X., Chow, E. K., Ho, D., Kabanov, A. V., Karp, J. M., Kataoka, K., Mirkin, C. A., Petrosko, S. H., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03569 · Cited by 338
Self-citationPoly(2‐Oxazoline)s – Are They More Advantageous for Biomedical Applications Than Other Polymers?
Sedlacek, O., Monnery, B. D., Filippov, S. K., Hoogenboom, R., & Hruby, M. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200453 · Cited by 312
Jia, F., Liu, X., Li, L., Mallapragada, S., Narasimhan, B., & Wang, Q. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.012 · Cited by 223
Poly(2-oxazoline)s as materials for biomedical applications
de la Rosa, V. R. (2014) · Journal of Materials Science: Materials in Medicine · doi:10.1007/s10856-013-5034-y · Cited by 218
Wan, X., Beaudoin, J. J., Vinod, N., Min, Y., Makita, N., Bludau, H., Jordan, R., Wang, A., Sokolsky, M., & Kabanov, A. V. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.032 · Cited by 201
“Interestingly, despite the mild hydrophobicity of the core-forming PBuOx block, we have found that triblock copolymer P(MeOx-BuOx-MeOx) exhibits an unprecedentedly high capacity for solubilization of extremely hydrophobic drugs, including taxanes, and several drug combinations [13, 14].”
BackgroundSelf-citationHe, Z., Wan, X., Schulz, A., Bludau, H., Dobrovolskaia, M. A., Stern, S. T., Montgomery, S. A., Yuan, H., Li, Z., Alakhova, D., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.002 · Cited by 197
Self-citationMiao, L., Guo, S., Zhang, J., Kim, W. Y., & Huang, L. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201401076 · Cited by 177
Polymeric Micelles for Multi-Drug Delivery in Cancer
Cho, H., Lai, T. C., Tomoda, K., & Kwon, G. S. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-014-0251-3 · Cited by 159
Wan, X., Min, Y., Bludau, H., Keith, A., Sheiko, S. S., Jordan, R., Wang, A. Z., Sokolsky-Papkov, M., & Kabanov, A. V. (2018) · ACS Nano · doi:10.1021/acsnano.7b07878 · Cited by 158
Self-citationDesign Strategies for Functionalized Poly(2-oxazoline)s and Derived Materials
Rossegger, E., Schenk, V., & Wiesbrock, F. (2013) · Polymers · doi:10.3390/polym5030956 · Cited by 177
Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers
Chen, W., Zhou, S., Ge, L., Wu, W., & Jiang, X. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00218 · Cited by 151
Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s
Schulz, A., Jaksch, S., Schubel, R., Wegener, E., Di, Z., Han, Y., Meister, A., Kressler, J., Kabanov, A. V., Luxenhofer, R., et al. (2014) · ACS Nano · doi:10.1021/nn406388t · Cited by 142
“15 With several drugs but especially with PTX, docetaxel (DTX), and 17-allylamino-17-demethoxygeldanamycin (17-AAG) longterm stable micellar formulations were obtained, with no significant changes of the micellar size or size distribution over a time period of at least 14 days.(16)”
BackgroundInfluentialSelf-citationPoly(2-oxazoline)-based micro- and nanoparticles: A review
Wilson, P., Ke, P. C., Davis, T. P., & Kempe, K. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.09.011 · Cited by 136
Drug Delivery Systems Based on Poly(2‐Oxazoline)s and Poly(2‐Oxazine)s
Sedláček, O., & Hoogenboom, R. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900168 · Cited by 135
Poly(ethylene glycol) alternatives in biomedical applications
Yao, X., Qi, C., Sun, C., Huo, F., & Jiang, X. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101738 · Cited by 138
Can nanomedicines kill cancer stem cells?
Zhao, Y., Alakhova, D. Y., & Kabanov, A. V. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.016 · Cited by 137
Self-citationLübtow, M. M., Hahn, L., Haider, M. S., & Luxenhofer, R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05376 · Cited by 120
Self-citationAgile delivery of protein therapeutics to CNS
Yi, X., Manickam, D. S., Brynskikh, A. M., & Kabanov, A. V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.017 · Cited by 126
Self-citationZahoranová, A., & Luxenhofer, R. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001382 · Cited by 119
Self-citationBiodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer
Desale, S. S., Cohen, S. M., Zhao, Y., Kabanov, A. V., & Bronich, T. K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.026 · Cited by 110
Self-citationZhang, J., Miao, L., Guo, S., Zhang, Y., Zhang, L., Satterlee, A., Kim, W. Y., & Huang, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.016 · Cited by 110
Jana, S., & Uchman, M. (2020) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2020.101252 · Cited by 119
Polyoxazoline: A review article from polymerization to smart behaviors and biomedical applications
Mahand, S. N., Aliakbarzadeh, S., Moghaddam, A., Moghaddam, A. S., Kruppke, B., Nasrollahzadeh, M., & Khonakdar, H. A. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111484 · Cited by 117
Haider, M. S., Lübtow, M. M., Endres, S., Forster, S., Flegler, V. J., Böttcher, B., Aseyev, V., Pöppler, A.-C., & Luxenhofer, R. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22495 · Cited by 100
Self-citationHe, Z., Schulz, A., Wan, X., Seitz, J., Bludau, H., Alakhova, D. Y., Darr, D. B., Perou, C. M., Jordan, R., Ojima, I., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.024 · Cited by 99
Self-citationSarkar, N., & Bose, S. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22474 · Cited by 94
Xiong, Y., Zhao, Y. D., Miao, L., Lin, C. M., & Huang, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.005 · Cited by 91
Nanoparticle-based combination drug delivery systems for synergistic cancer treatment
Choi, J. Y., Thapa, R. K., Yong, C. S., & Kim, J. O. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0252-1 · Cited by 91
Ding, L., Wang, Q., Shen, M., Sun, Y., Zhang, X., Huang, C., Chen, J., Li, R., & Duan, Y. (2017) · Autophagy · doi:10.1080/15548627.2017.1320634 · Cited by 85
Polyoxazoline biointerfaces by surface grafting
Morgese, G., & Benetti, E. M. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.11.003 · Cited by 87
Polymeric Micelles for Multidrug Delivery and Combination Therapy
Aw, M. S., Kurian, M., & Lošić, D. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201302097 · Cited by 83
Nanoparticle-Based Approaches for Treatment of Hematological Malignancies: a Comprehensive Review
Hani, U., Gowda, B. H. J., Haider, N., Ramesh, K. V., Paul, K., Ashique, S., Ahmed, M. G., Narayana, S., Mohanto, S., & Kesharwani, P. (2023) · AAPS PharmSciTech · doi:10.1208/s12249-023-02670-0 · Cited by 77
Recent advances in co-delivery nanosystems for synergistic action in cancer treatment
de Carvalho, B. G., Vit, F. F., Carvalho, H. F., Han, S. W., & de la Torre, L. G. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02168g · Cited by 75
Amphiphilic poly(2-oxazoline) copolymers as self-assembled carriers for drug delivery applications
Vlassi, E., Papagiannopoulos, A., & Pispas, S. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.10.034 · Cited by 74
Cai, H., Wang, R., Guo, X., Song, M., Yan, F., Ji, B., & Liu, Y. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c01225 · Cited by 72
Seo, Y., Schulz, A., Han, Y., He, Z., Bludau, H., Wan, X., Tong, J., Bronich, T. K., Sokolsky, M., Luxenhofer, R., et al. (2015) · Polymers for Advanced Technologies · doi:10.1002/pat.3556 · Cited by 67
Self-citationZhang, N., Luxenhofer, R., & Jordan, R. (2012) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201200261 · Cited by 73
Self-citationCheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs
Alves, V. M., Hwang, D., Muratov, E., Sokolsky-Papkov, M., Varlamova, E., Vinod, N., Lim, C., Andrade, C. H., Tropsha, A., & Kabanov, A. (2019) · Science Advances · doi:10.1126/sciadv.aav9784 · Cited by 56
Self-citationНеганова, М. Е., Aleksandrova, Y. R., Sukocheva, O. A., & Klochkov, S. G. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.06.011 · Cited by 58
Hwang, D., Dismuke, T., Tikunov, A., Rosen, E. P., Kagel, J. R., Ramsey, J. D., Lim, C., Zamboni, W., Kabanov, A. V., Gershon, T. R., et al. (2021) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2020.102345 · Cited by 53
Self-citationHahn, L., Lübtow, M. M., Lorson, T., Schmitt, F., Appelt‐Menzel, A., Schobert, R., & Luxenhofer, R. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00708 · Cited by 60
Self-citationChoudhury, H., Maheshwari, R., Pandey, M., Tekade, M., Gorain, B., & Tekade, R. K. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110275 · Cited by 48
Self‐Assembly of Amphiphilic Block Copolypeptoids with C 2 ‐C 5 Side Chains in Aqueous Solution
Fetsch, C., Flecks, S., Gieseler, D., Marschelke, C., Ulbricht, J., PÉE, K.-H. V., & Luxenhofer, R. (2014) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201400534 · Cited by 51
Self-citationA Low Protein Binding Cationic Poly(2‐oxazoline) as Non‐Viral Vector
He, Z., Miao, L., Jordan, R., S‐Manickam, D., Luxenhofer, R., & Kabanov, A. V. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500021 · Cited by 47
Self-citationDesale, S. S., Raja, S. M., Kim, J. O., Mohapatra, B. C., Soni, K. S., Luan, H., Williams, S. H., Bielecki, T. A., Feng, D., Storck, M. D., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.001 · Cited by 45
Self-citationGuo, D., Shi, C., Wang, X., Wang, L., Zhang, S., & Luo, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.041 · Cited by 45
Advancements and Challenges in Multidomain Multicargo Delivery Vehicles
Pugliese, E., Coentro, J. Q., & Zeugolis, D. I. (2018) · Advanced Materials · doi:10.1002/adma.201704324 · Cited by 44
Zhu, Y., Yu, F., Tan, Y., Hong, Y. K., Meng, T., Liu, Y., Dai, S., Qiu, G., Yuan, H., & Hu, F. (2019) · Theranostics · doi:10.7150/thno.36334 · Cited by 43
Lim, C., Dismuke, T., Malawsky, D. S., Ramsey, J. D., Hwang, D., Godfrey, V., Kabanov, A. V., Gershon, T. R., & Sokolsky‐Papkov, M. (2022) · Science Advances · doi:10.1126/sciadv.abl5838 · Cited by 43
Self-citationPoly(2-oxazoline)–Pterostilbene Block Copolymer Nanoparticles for Dual-Anticancer Drug Delivery
Romio, M., Morgese, G., Trachsel, L., Babity, S., Paradisi, C., Brambilla, D., & Benetti, E. M. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01279 · Cited by 40
Haryadi, B. M., Hafner, D., Amin, I., Schubel, R., Jordan, R., Winter, G., & Engert, J. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900352 · Cited by 37
Self-citationHaider, M. S., Ahmad, T., Yang, M., Hu, C., Hahn, L., Stahlhut, P., Gröll, J., & Luxenhofer, R. (2021) · Gels · doi:10.3390/gels7030078 · Cited by 40
Self-citationPharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide
Najar, I. A., & Johri, R. K. (2014) · Journal of Biosciences · doi:10.1007/s12038-013-9399-3 · Cited by 37
Luxenhofer, R. (2015) · Nanomedicine · doi:10.2217/nnm.15.139 · Cited by 42
Self-citationMaleimide‐Functionalized Poly(2‐Oxazoline)s and Their Conjugation to Elastin‐Like Polypeptides
Nawroth, J. F., McDaniel, J. R., Chilkoti, A., Jordan, R., & Luxenhofer, R. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201500376 · Cited by 39
Self-citationZahoranová, A., Mrlík, M., Tomanová, K., Kronek, J., & Luxenhofer, R. (2017) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201700031 · Cited by 39
Self-citationFolate-targeted pH-sensitive bortezomib conjugates for cancer treatment
Liu, Y., Dai, Z., Wang, J., Tu, Y., & Zhu, L. (2019) · Chemical Communications · doi:10.1039/c9cc01344j · Cited by 33
Cancer Stem Cells and Personalized Cancer Nanomedicine
Gener, P., Rafael, D. F. D. S., Fernández, Y., Sayós, J., Arango, D., Abasolo, I., Videira, M., & Schwartz, S. (2016) · Nanomedicine · doi:10.2217/nnm.15.200 · Cited by 31
Micronization of etoposide using solution-enhanced dispersion by supercritical CO2
Cheng, Y., Xu, W., Chen, Z., Wang, Z., & Huang, D. (2016) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2016.03.006 · Cited by 31
Porous Poly(2-oxazoline)-Based Polymers for Removal and Quantification of Phenolic Compounds
Cegłowski, M., Schroeder, G., & Hoogenboom, R. (2020) · Chemistry of Materials · doi:10.1021/acs.chemmater.0c01559 · Cited by 31
Poly(2-oxazoline)-Containing Triblock Copolymers: Synthesis and Applications
Sahn, M., Weber, C., & Schubert, U. S. (2019) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583724.2018.1496930 · Cited by 29
Zhong, P., Qiu, M., Zhang, J., Sun, H., Cheng, R., Deng, C., Meng, F., & Zhong, Z. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa76cc · Cited by 28
Cegłowski, M., Marien, Y. W., Smeets, S., Smet, L. D., D’hooge, D., Schroeder, G., & Hoogenboom, R. (2021) · Chemistry of Materials · doi:10.1021/acs.chemmater.1c02813 · Cited by 27
Cegłowski, M., & Hoogenboom, R. (2018) · Macromolecules · doi:10.1021/acs.macromol.8b01068 · Cited by 27
POxload: Machine Learning Estimates Drug Loadings of Polymeric Micelles
Kehrein, J., Bunker, A., & Luxenhofer, R. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00086 · Cited by 28
Self-citationHuntošová, V., Datta, S., Lenkavská, L., Máčajová, M., Bilčík, B., Kundeková, B., Čavarga, I., Kronek, J., Jutková, A., Miškovský, P., et al. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00768 · Cited by 27
Hartlieb, M., Pretzel, D., Wagner, M., Hoeppener, S., Bellstedt, P., Görlach, M., Englert, C., Kempe, K., & Schubert, U. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02069c · Cited by 25
Landry, M. R., DuRoss, A. N., Neufeld, M. J., Hahn, L., Sahay, G., Luxenhofer, R., & Sun, C. (2020) · Materials Today Bio · doi:10.1016/j.mtbio.2020.100082 · Cited by 28
Self-citationPoly(2-oxazoline)s: synthesis and biomedical applications
Yang, L., Wang, F., Ren, P., Zhang, T., & Zhang, Q. (2023) · Macromolecular Research · doi:10.1007/s13233-023-00116-x · Cited by 27
Hartshorn, C. M., Russell, L. M., & Grodzinski, P. A. (2019) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1570 · Cited by 27
Bai, J., Tian, Y., Liu, F., Li, X., Shao, Y., Lu, X., Wang, J., Zhu, G., Xue, B., Liu, M., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b01827 · Cited by 23
Intelligent micellar polymeric nanocarriers for therapeutics and diagnosis
Topete, A., Barbosa, S., & Taboada, P. (2015) · Journal of Applied Polymer Science · doi:10.1002/app.42650 · Cited by 25
Haider, M. S., Schreiner, J., Kendl, S., Kroiß, M., & Luxenhofer, R. (2019) · Macromolecular Bioscience · doi:10.1002/mabi.201900178 · Cited by 23
Self-citationDong, S., Ma, S., Liu, Z., Ma, L., Zhang, Y., Tang, Z., Deng, M., & Song, W. (2021) · Chinese Journal of Polymer Science · doi:10.1007/s10118-021-2547-6 · Cited by 21
Cheng, Q., Zhong, X., Deng, L., He, X., Luo, M., Wang, R., & Zhang, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500446 · Cited by 20
Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
Caimano, M., Severini, L. L., Loricchio, E., Infante, P., & Marcotullio, L. D. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.688108 · Cited by 19
Dong, S., Ma, S., Chen, H., Tang, Z., Song, W., & Deng, M. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.04.006 · Cited by 18
Jaksch, S., Schulz, A., Kyriakos, K., Zhang, J., Grillo, I., Pipich, V., Jordan, R., & Papadakis, C. M. (2014) · Colloid & Polymer Science · doi:10.1007/s00396-014-3333-6 · Cited by 18
Self-citationNanoscale platform for delivery of active IRINOX to combat pancreatic cancer
Lei, F., Xi, X., Rachagani, S., Seshacharyulu, P., Talmon, G. A., Ponnusamy, M. P., Batra, S. K., & Bronich, T. K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.029 · Cited by 16
Self-citationKostova, B., Ivanova, S., Balashev, K., Rachev, D., & Christova, D. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0120-0 · Cited by 15
Seo, Y., Ghazanfari, L., Master, А. M., Vishwasrao, H. M., Wan, X., Sokolsky‐Papkov, M., & Kabanov, A. V. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102459 · Cited by 17
Self-citationPoly(2‐oxazoline)‐Based Polyplexes as a PEG‐Free Plasmid DNA Delivery Platform
Yamaleyeva, D. N., Makita, N., Hwang, D., Haney, M. J., Jordan, R., & Kabanov, A. V. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300177 · Cited by 14
Self-citationWang, Y., Tian, Y., Zhu, P., Ma, Y., He, J., & Lei, J. (2017) · RSC Advances · doi:10.1039/c7ra04366j · Cited by 13
Haider, M. S., Mahato, A. K., Котлярова, А. А., Forster, S., Böttcher, B., Stahlhut, P., Sidorova, Y. A., & Luxenhofer, R. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00761 · Cited by 14
Self-citationVillar‐Álvarez, E., Ochoa, E. B. F., Barbosa, S., Soltero, J. F. A., Taboada, P., & Mosquera, V. (2015) · RSC Advances · doi:10.1039/c5ra07296d · Cited by 14
Verbraeken, B., Lava, K., & Hoogenboom, R. (2014) · Wiley eBooks · doi:10.1002/0471440264.pst626 · Cited by 17
Soni, K. S., Lei, F., Desale, S. S., Marky, L. A., Cohen, S. M., & Bronich, T. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.038 · Cited by 13
Self-citationZeng, H., Li, X., Liu, Y., Li, X., Qu, D., & Chen, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2147601 · Cited by 11
Cholic Acid-Based Novel Micellar Nanoplatform for Delivering FDA-Approved Taxanes
Bharadwaj, G., Nhan, V., Yang, S., Li, X., Narayanan, A., Macarenco, A. C., Shi, Y., Yang, D., Vieira, L. S., Xiao, W., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0361 · Cited by 11
Poly(2‐Hydroxymethyl‐2‐Oxazoline) as Super‐Hydrophilic Antifouling Polymer
Jana, S., Roels, M., Leiske, M. N., Bernhard, Y., Geest, B. G. D., Hecke, K. V., & Hoogenboom, R. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202424873 · Cited by 12
Poly(2-oxazoline)-based drug delivery systems for cancer therapy
Kulkarni, B., & Becer, C. R. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.114292 · Cited by 10
Xu, Y., Tang, L., Liu, Y., Qian, C., Chen, P., Xin, Y., Liu, H., & Qu, Y. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111642 · Cited by 9
Metadata
- Authors
- Han, Y., He, Z., Schulz, A., Bronich, T. K., Jordan, R., Luxenhofer, R., & Kabanov, A. V.
- Affiliations
- Wuhan University of Technology (CN)
- University of Nebraska Medical Center (US)
- Technische Universität Dresden (DE)
- Lomonosov Moscow State University (RU)
- Corresponding author
- Luxenhofer, Robert
- Kabanov, Alexander V.
- ORCID
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-06-28
- Volume
- 9
- Issue
- 8
- Pages
- 2302-2313
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- PMC
- PMC3534837
- OpenAlex
- W2027018089
- Semantic Scholar
- 01a9d840f24848c24560e63ca4db63dfc02015e0
- Cited by
- 125
- References
- 59
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 8 · 2012: 4
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U01 CA116591, U01CA151806, R01CA116591, P30CA036727)
- National Institute of General Medical Sciences (P20GM103480)
- National Center for Research Resources (RR-021937, P20RR021937)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- combination chemotherapy, drug loading capacity, paclitaxel, docetaxel, 17-AAG, etoposide, bortezomib, synergistic cytotoxicity, poorly water-soluble drugs, drug solubilization, MCF-7 cells
- MeSH terms
- Docetaxel, Antineoplastic Agents, Cell Survival, Drug Carriers, Etoposide, Humans, Micelles, Oxazoles, Benzoquinones, Drug Delivery Systems, Taxoids, Cell Line, Tumor, Lactams, Macrocyclic, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.